Great to see that @oxcio.bsky.social Max is thinking big before his DPhil viva this morning! #croissantasaurusrex

Great discussion - patient groups are central to A/I partnerships -especially in the ED/prevention space….

Congratulations Liz! Read her historical perspective article in @imtadvances.bsky.social

Congress starts today in Liverpool. Immunologists are battling the elements to be together! See you there.

🧬 Therapeutic cancer vaccines are back in focus! Advances in neo-antigen T cells, dendritic cell biology, and mRNA tech are paving the way for next-gen immunotherapy. Read the Open Access review: https://bit.ly/4cefxGm #CancerVaccines #Immunotherapy #mRNA #Oncology

🦠 DC3s in solid tumours can prime T cells and influence outcomes—boosting survival in some cancers, but promoting immunosuppression in others. 👉 https://bit.ly/3T2blRg ##Immunotherapy #CancerImmunology

🔬 First head-to-head comparison of nuclear imaging for tumour CD8⁺ T cells shows [⁸⁹Zr]Zr-anti-CD8-IgG2a(silent) & [⁸⁹Zr]Zr-OT-I track T-cell infiltration & migration, aiding immunotherapy strategies. 👉 https://bit.ly/4ncWCzv ##Immunotherapy #CD8Tcells #CancerResearch

Congratulations, Michael! 🎉

Agreed. Pipette for Power!

Offer cancer patients exercise on NHS major charity urges www.theguardian.com/society/2025...

It seems someone removed the beautiful local multinational flag from the lamppost in East Oxford, but someone else has put up another one. nextdoor.co.uk/p/8TdLxGqcS_...

Incredible #infection #immunity #cancer #Bcells #Tcells Resource 👏 Top of the Human League 🙋‍♂️🙋‍♀️

From CAR-NK cells to checkpoint inhibitors, Blunt & Khakoo review how boosting NK-cell function could transform cancer therapy. 🔓 Open access: https://bit.ly/4j8dKEW #Immunotherapy #NKcells #CancerResearch

UK NK 2026 in Cardiff. January 9th. Be there. eventbrite.co.uk/e/uk-nk-confer… Hosted by Rich Stanton, Ceri Fielding & Eddie Wang

Need funding to attend your next conference? 💡 The BSI Conference Travel Grants can cover your travel costs - UK (£500), Europe (£700), rest of world (£1,000). The deadline is just over 1 week away (1 November), so submit your application soon! https://bit.ly/3U0jk2E

@witherslab.bsky.social going from strength to strength

Tick what? Many happy returns Felipe and well marked Anjum!

4 decades of IO – Celebrating 40 years of SITC. In 2009, we had a record meeting attendance and abstract submission! Attend this year's 40th Anniversary Annual Meeting and be a part of the science. https://www.sitcancer.org/2025/home

Wonderful day celebrating Paul Nurse after he steps down from being the Director @crick.ac.uk. We are all very grateful to him for having created an amazing institute.

@blackwellbooks.bsky.social please start posting

Great to see our work on preventive cancer vaccines, including LungVax, featured in this issue! @oxfordcancer.bsky.social @sarahblagden.bsky.social @timmunologist.bsky.social

Join us for our DPhil in Cancer Science Open Day on Tuesday 2nd September at 12:30pm to find out how a DPhil can be the next step in your cancer research career development! Register via our Eventbrite link before 1st Sept⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk www.eventbrite.co.uk/e/university...

Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬

Amazing news for our Institute @kiroxford.bsky.social @ox.ac.uk 🎉🍾😀 ! Looking forward to working with our @manchester.ac.uk colleagues to understand better how envrionmental determinants drive chronic inflammatory diseases !

Targeting monocyte dynamics in MS? In Immunotherapy Advances, Bibi et al. explore how shifting monocytes from inflammatory to reparative states may reshape MS treatment strategies. 📘 https://bit.ly/3EXOfaV ##MS #Monocytes #Neuroinflammation

New research by Rui Zhao et al. shows that high anti-drug antibody (ADA) levels after 3 cycles of camrelizumab are linked to shorter survival in patients with advanced solid cancers. 📉 Higher ADA = lower drug levels = worse outcomes. 🔗 https://bit.ly/461mc5B ##Immunotherapy #CancerResearch

🧬 Better understanding of immune rejection and evasion is setting the stage for next-gen therapies. Elizabeth Simpson reviews how foundational immunology is reshaping transplant and cancer treatment. 📖 https://bit.ly/44N141N ##TransplantImmunology #Immunotherapy

🧩 Antigen presentation is complex - but imaging is bringing clarity. @doreenlau.bsky.social‬ & @timmunologist.bsky.social‬ review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity. 📖 https://bit.ly/3TkIasN ##CancerImmunology

A high-affinity TCRxCD3 bispecific (ImmTAC®) efficiently redirects T cells to kill PRAME+ tumor cells, even at low epitope density. Combination with anti-PD-1 restores activity in exhausted T cells. One of the most read articles in ITA: https://bit.ly/40o5kT8 ##immunology

Mechanistic modelling reveals that both antigen-dependent and independent factors shape CAR T-cell dynamics in month-one lymphoma patients. IL-7/IL-15 levels and lymphodepletion matter more than CAR T-cell phenotype. 📖 Read: https://bit.ly/3U6fDY6 ##Immunotherapy

Yesterday we finished with prize-giving and drinks in the garden🥂🌱! 🏆 Posters for Bas, Cindy & Charlotte📃; postdoc talk for Qian 👩‍🏫 & best embossing artwork for Group8 🧑‍🎨 Shoutout to Lisha for the Rhodes House tours, acknowledging its history, the good and the uncomfortable ⚖️. What a day! #CIOawayday

✨ Kicking off #CIOawayday with our senior PIs sharing the experiments that changed their careers 🧑‍🔬👩‍🔬🧫 A reminder that serendipity, curiosity, and pub chats can spark groundbreaking ideas 🤓 Clearly science thrives on kindness and collaboration and we got a lot of that in #CIO 😉🙃 #ScienceLife

🔬 Call for papers: We invite submissions for a special collection on Immunotherapies for Inborn Errors of Immunity. Explore genetics-guided, targeted treatments for primary immunodeficiency and immune dysregulation. 🗓️ Submit by Sept 2025 📖 Info: https://bit.ly/40o5kT8 ##Immunotherapy

#Bridge2ABetterFuture Challenge #10 complete with sueduncombe.bsky.social - the @cancerresearch.uk.org Big Hike (Cotswolds). 14 miles over the hills in the heatwave! Big steps bringing big discoveries Thanks for all donations fundraise.cancerresearchuk.org/page/bridge-... @oxfordcancer.bsky.social

Wonderful personal perspective from one of the founders of modern immunology

🚨 Last chance! Just a few days left to submit to our Special Collection: Imaging in Immunotherapy. Showcase your research in molecular imaging, immune monitoring, and image-guided drug delivery. Deadline: June 2025 🧬🖼️ #Immunotherapy #MolecularImaging 📩 Submit now: https://bit.ly/4j8c265

🚨 Researchers at over 120 UK institutions can publish open access for free in Immunotherapy Advances! No APC's, just impactful immunotherapy research shared with the world. 🌐 #OpenScience 🔗 Check eligibility here: bit.ly/4no9OTy

🫁 New study: M2 macrophages ease asthma symptoms in mice by boosting IL-10⁺ B-cell production via the TGF-β & oxidative phosphorylation pathways. 💡 Highlights the regulatory role of macrophage–B cell interactions in asthma. 🔗 Read more: https://bit.ly/4kXzogj

A big part of the CIO team will be at #BSI2025 🤓 especially now that our very own Max from the @ggillesp.bsky.social lab is featured on the conference poster! Looking forward to an exciting few days in Liverpool 🔬✨ #Immunology #CIOonTour

And we're off! Conference Co-Chair and @oncology.ox.ac.uk's Professor of Experimental Oncology @sarahblagden.bsky.social opens day two of the Cancer Prevention Research Conference in London.

Intramolecular Active displacement of common MHC I- peptide interactions drives peptide editing. Thanks for the call out Chris!

Really important to see the research generating a solid and powerful evidence base needed to help governments undo health inequalities

It’s under publicised that MANY universities and institutions around the world can publish in ITA for FREE under the read and publish deals with OUP. There are still inequalities - especially painful for BRIC who have great research infrastructure but no R&P deals yet. I hope this will change.

Review: From computational models of the splicing code to regulatory mechanisms and therapeutic implications https://www.nature.com/articles/s41576-024-00774-2 (read free: https://rdcu.be/dVNV4)

Great panel discussion chaired by our own @timmunologist.bsky.social on 'the role of immune dysfunction in cancer development and prevention' at today's Cancer Prevention Research Conference! @cancerresearchuk.org @americancancersoc.bsky.social

Immunology x cancer prevention = exciting research x healthy living

Feeling proud and looking sharp! Repping the Centre for Immuno-Oncology in style 😎 🔥Our top models, @anthonyhsieh.bsky.social and @mjwsim.bsky.social, rocking the CIO polos, in black and navy, which seems to be the unofficial Friday uniform around here! Team spirit (and outfits) on point 💛🖤💙

🔍 What do we really know about DC3s in solid tumors? This new article explores the phenotype, function & impact of DC3s across cancers - highlighting their complex roles in both immunity & immunosuppression. 📖 Read it now: https://bit.ly/3T2blRg ##Immunotherapy

Hi there @bsi-cipn.bsky.social - this is a great destination for your latest manuscript!